Yezan Munther Haddadin Outlook Therapeutics, Inc. (OTLK) insider trading activity

OTLK Quotes by TradingView

Yezan Munther Haddadin is of Outlook Therapeutics, Inc.. Currently has a direct ownership of 5,048 shares of OTLK, which is worth approximately $25,391. The most recent transaction as insider was on Mar 28, 2024, when has been sold 1,881 shares (Common Stock) at a price of $11.82 per share, resulting in proceeds of $22,233. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.05K
0% 3M change
92.03% 12M change
Total Value Held $25,391

Yezan Munther Haddadin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 28 2024
BUY
Open market or private purchase
$22,233 $11.82 p/Share
1,881 Added 27.15%
5,048 Common Stock
Oct 07 2022
BUY
Open market or private purchase
$4,572 $1.27 p/Share
3,600 Added 5.38%
63,343 Common Stock
Oct 06 2022
BUY
Open market or private purchase
$38,368 $1.29 p/Share
29,743 Added 33.24%
59,743 Common Stock
Dec 02 2021
BUY
Open market or private purchase
$13,900 $1.39 p/Share
10,000 Added 25.0%
30,000 Common Stock
Apr 19 2021
BUY
Open market or private purchase
$18,200 $1.82 p/Share
10,000 Added 33.33%
20,000 Common Stock
YMH

Yezan Munther Haddadin

Monmouth Junction, NJ

Track Institutional and Insider Activities on OTLK

Follow Outlook Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OTLK shares.

Notify only if

Insider Trading

Get notified when an Outlook Therapeutics, Inc. insider buys or sells OTLK shares.

Notify only if

News

Receive news related to Outlook Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on OTLK